MicroSectors Cannabis ETNs

MicroSectors Cannabis ETNs

MJJ
MicroSectors Cannabis ETNsUS flagNew York Stock Exchange Arca
- -
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
Sector
Financial Services
Industry
Asset Management
Address
United States of America
IPO Date
Dec 10, 2019
Business
MicroSectors Cannabis ETNs (MJJ) is an exchange-traded note issued by Bank of Montreal that provides unleveraged exposure to the performance of the Indxx North American Cannabis Index, minus applicable fees; the index tracks North American companies involved in products or services for medical or industrial cannabis use, with a market cap-weighted and liquidity-adjusted composition featuring constituents such as AbbVie Inc. The ETN trades on NYSE Arca under the ticker MJJ with intraday indicative value ticker MJJIV, CUSIP 63679682, issued on December 13, 2019, and maturing on November 17, 2039; approximately 600,000 ETNs remain outstanding. Launched by REX Shares in partnership with Bank of Montreal, headquartered in New York for product management and Toronto for the issuer, it targets investors seeking targeted cannabis sector exposure without leverage, distinct from the related MicroSectors Cannabis 2X Leveraged ETN (MJO). No major recent partnerships, acquisitions, funding rounds, product launches, or strategic shifts specific to MJJ have been announced in the last 1-2 years, though the product has benefited from broader cannabis sector surges driven by U.S. regulatory reform expectations under President Trump in December 2025.